Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

NY-based PE firm Warburg Pincus exits India’s pharmacy chain MedPlus

Warburg Pincus, a global private equity firm based in New York, exited Indian pharmacy chain MedPlus Health Services on August 26, selling its entire 11.4% stake for approximately $100 million through an open market transaction. The sale was carried out by its Mauritius-based unit, Lavender Rose Investment Ltd.

Final two companies selected for billion-dollar Canberra hospital tender

The Australian Capital Territory (ACT) Government has announced the final shortlist of two property development companies for its new hospital project tender. Spain's Grupo ACS, through its Australian subsidiary Cimic and its construction arm CPB Contractors, has secured a place on the shortlist and will compete against London-based and Australia-founded firm Multiplex Construction.
With an investment […]

Interview: Dom Longford, Cog ADHD

Cog ADHD is a digital platform for people with ADHD. The company officially launched its new app on iOS and Android earlier this month. Dom Longford, the company’s founder, explained to HBI how the platform's holistic approach to supporting people with ADHD can help fill the gaps left by failing public mental health systems.

Brookfield Asset Management takeover of Grifols continues to progress with new debt financing move

The anticipated Brookfield Asset Management takeover of Catalonia’s Grifols has gathered fresh momentum, with the firm reportedly in talks with banks to secure approximately €9.5 billion in debt financing towards the deal, according to Bloomberg sources.  The Canadian investment firm is exploring the acquisition in partnership with the Grifols family, who hold a ~30% stake […]

FREE BLOG Hyperspecialisation in healthcare — an area for PE investors to watch

Here at HBI, we’re always exploring innovative ways to deliver healthcare content to our readers.  I recently read an article on LinkedIn titled ‘The Double-Edged Sword of Hyperspecialisation in Medicine: Challenges of Choosing the Right Doctor’. This article prompted me to reflect on how hyperspecialisation impacts patient care and its implications for healthcare investors, especially given […]

KKR, TPG Capital, and Apax Partners front-run the acquisition of India’s cardiac stent maker SMT

US-based global investment company KKR, private equity firm TPG Capital, and British private equity firm Apax Partners are reportedly exploring an investment in India’s Sahajanand Medical Technologies (SMT), Economic Times reported. SMT is a developer and manufacturer of minimally invasive coronary stent systems, valued at Rs 3,500-4,000 crore (~$420-480 million USD). Alongside KKR, TPG Capital, […]

HBI News Round Up, Friday 23rd August 2024

In this HBI News Round Up we cover Hallo Healthcare Group’s exit from the healthcare services sector, Genesis MedTech’s sale of its subsidiary, JC Medical Inc to Edwards Lifesciences, biopharmaceutical company, Vertex Pharmaceuticals obtaining of a licence for CASGEVY in the UK, disease risk detection and preventative health company, Nightingale Health’s attaining of UK Conformity […]

Find Us